LLY going lower Healthcare has been a safe bet this past year and is starting to look weak across the board. The sector is usually defensive, but it feels overbought. Should see continued selling.
Short term PT: $320
LLY
SHORT LLY: OVER VALUED - REV AND EARNINGS GROWTH NEGATIVE trading 50x earnings. negative earnings and rev growth. MAX short. stops 380 2x consecutive daily closes ABOVE. upside 20-30%
LLY | LongThis week a Twitter user bought a blue tick by spending $8 to post a fake tweet "insulin will be free now". Major Insulin producer LLY erased $30 billion in market cap. in a single day. Fundamentally this stock has a huge P/E ratio, in spide, there still has growth potential for that underlying. IMO LLY will retest new highs.
LLYthe health services and health technology sectors were the first to receive investment and bullish speculative pressures as the dollar fell
that is, drugs and vaccines never go into crisis .. even LLY has never even dropped below the 200 daily moving average this year, like very few stocks
and has now confirmed a bullish symmetrical triangle, I buy now and on GAP 343 retracement
Long the Support Retest for 50% upside into 2024-2025This is a low risk high reward gem.
90,000 employees is too many, look for a lay-off announcement to drive down price allowing for an ideal entry at $30.00
LLY daily indecision candle overpriced at all time highOrder SELL LLY NYSE Stop 325.50 LMT 325.50 will be automatically canceled at 20230101 00:00:00 EST
LLY daily indecision candle overpriced at all time high retest gap with exhaustion volume.
MSFT SHORT
study(title="BestIntradayTips", shorttitle="BIT", precision=0, overlay=true, scale=scale.left)
trendDetectionLength=input(2)
showDistributionBelowZero=input(false, type=bool)
mov = close>close ? 1 : close= dif
wave=(trend != nz(wave )) and isTrending ? trend : nz(wave )
vol=wave==wave ? (nz(vol )+volume) : volume
up=wave == 1 ? vol : 0
dn=showDistributionBelowZero ? (wave == 1 ? 0 : wave == -1 ? -vol : vol) : (wave == 1 ? 0 : vol)
input_src = wave == 1 ? vol : 0
input_ma_period = input(50, title="Moving average")
input_max_height = input(1000, title="Maximum value on left bar")
ma = sma(input_src, input_ma_period)
normalized_volume = min(input_src / ma * 100, input_max_height * 1)
plot(input_max_height, transp=100, title="")
//
input_src1 = showDistributionBelowZero ? (wave == 1 ? 0 : wave == -1 ? -vol : vol) : (wave == 1 ? 0 : vol)
input_ma_period1 = input(50, title="Moving average")
input_max_height1 = input(1000, title="Maximum value on left bar")
hline(0)
hline(250)
hline(500)
hline(750)
ma1 = sma(input_src1, input_ma_period1)
normalized_volume1 = min(input_src1 / ma1 * 100, input_max_height1 * 1)
resCustom = input(title="Timeframe", type=resolution, defval="1440" )
v=security(tickerid, resCustom,normalized_volume)
resCustom1 = input(title="Timeframe", type=resolution, defval="1440" )
v1=security(tickerid, resCustom,normalized_volume1)
a=v>0 and v1<50
b=v1>0 and v<50
bgcolor(a > 0 ? blue : na, transp=80)
bgcolor(b > 0 ? red : na, transp=80)
$LLY Keep on your portfolio!Eli Lilly and Company is showing a strong momentum ahead of earning report.
its one of by favorite ones.
--TradeWise--
$LLY looks ready to breakout$LLY daily chart. IT closed nicely on Friday even though most of the stocks were down a lot. After an up move, it is now moving sideways inside this rectangular range. Looks ready for next upmove once we break this range on the upside. Once we break above 335, looking for a 8% up move in this one.
7/17/22 LLYEli Lilly and Company ( NYSE:LLY )
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $315.073B
Current Price: $331.60
Breakout price: $334.70
Buy Zone (Top/Bottom Range): $314.00-$292.90
Price Target: $364.20-$367.50 (2nd)
Estimated Duration to Target: 112-120d (2nd)
Contract of Interest: $LLY 10/21/22 350c
Trade price as of publish date: $13.50/contract
LLY Fib Circle Scenario (MACD top)Comparing two points of price and MACD
The MACD is very similar in both points, very over extended
This correlates well with the 1.618 fib level, which allows price to move down along the circle as the MACD retraces, as seen in the first scenario (0.618)
LLY at resistance and overbought historicallyWay overbought on all technicals, looking for a pullback to $270 range in the next week or so. Will add every $2 increase in stock price up. Will cover at or under target.
3/13/22 LLYEli Lilly and Company ( NYSE:LLY )
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $253.61B
Current Price: $266.30
Breakout price: $270.95 (hold above)
Buy Zone (Top/Bottom Range): $262.45-$247.10
Price Target: $308.00-$310.40
Estimated Duration to Target: 84-90d
Contract of Interest: $LLY 6/17/22 300c
Trade price as of publish date: $5.90/contract
Eli Lilly up and up. LLYShort term and temporarily.
Immediate targets 257, 263, 272. Invalidation 232.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
$BIIB: Update, get long!I think it warrants making a new publication here, $BIIB has flashed a buy signal with tremendously good reward to risk, as it can resume the long term trend that can take it over $1600-2600 over time. Phase 3 clinical trials have gone really well for their Alzheimer's treatment 'Aduhelm', putting it in line with results obtained by $LLY's drug 'Donanemab'. I was long $LLY and have been trading in and out of $BIIB trying to time the end of the long slide since the FDA approval news came out. I think the time is now, to get in and sit tight. I've banked my $LLY exposure, but both companies will likely do well with their Alzheimer's treatments going forward and have solid trends, but the reward to risk favors $BIIB, so I'm only long Biogen currently.
Best of luck!
Cheers,
Ivan.
Flat on Eli Lilly. LLYWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
LLY Long Opportunity LLY has provided a nice long opportunity with the recent break above the major trendline
This breakout is comparable to a previous point, which led to a large megaphone price structure
Price will likely stay above the trendline and climb within the megaphone (attempted to roughly sketch what it would look like)
LLY - STOCKS - 21. OCT. 2021Welcome to our Weekly V2-Trade Setup ( LLY ) !
-
4 HOUR
Small pullback towards previous sr level.
DAILY
Expecting more bullish pa!
WEEKLY
Overall great market structure.
-
STOCK SETUP
BUY LLY
ENTRY LEVEL @ 241.21
SL @ 231.90
TP @ Open
Max Risk: 0.5% - 1%!
(Remember to add a few pips to all levels - different Brokers!)
Leave us a comment or like to keep our content for free and alive.
Have a great week everyone!
ALAN
LLY trianglePulling back towards a potential buying zone ( 257.80 - 255.85)
Below that area we have a trendline that could also offer support.
Will wait for either a rejection off the buying zone or a break of the triangle
$LLY Bullish Pennant, Unusual Options Activity$LLY Bullish Pennant, Unusual Options Activity
$360M of January'22 deep in-the-money calls bought today (8-9x open interest)
On watch for a daily close outside the pennant (topside).
Near term target: $300-$310 range possible by early December
Note: This is NOT investment advice.
LLY moving to the top of this range.Just like my last post this is highlighting LLY moving up. Just with arrows this time lol
LLY moving to the top of this range.Looks as though it is moving to the top of the range I provided.
